Difficulty: Medium
Average Score: 82%
Practice
Muscarinic agonists such as pilocarpine, and $B$ blockers, are among the drugs used to manage a case of glaucoma, they also share properties that are particularly relevant to patients with asthma. Which of the following statements summarizes best what that relevance is?
Correct answer
A
Rationale
In the case of managing glaucoma, muscarinic agonists like pilocarpine and beta blockers are commonly used. These drugs can pose risks for patients with asthma due to their potential to exacerbate asthma symptoms. Muscarinic agonists can lead to bronchoconstriction by stimulating smooth muscle contraction in the airways, worsening asthma symptoms. Beta blockers, on the other hand, can cause bronchoconstriction by blocking beta-2 receptors in the lungs, which are responsible for bronchodilation.
Option A is correct because muscarinic agonists and beta blockers are contraindicated or pose great risks for individuals with asthma. It is crucial for healthcare providers to be aware of this interaction to avoid adverse effects in patients with both glaucoma and asthma.
Options B, C, and D are incorrect. Option B incorrectly suggests that these drugs degranulate mast cells and cause bronchoconstriction. Option C is inaccurate as these drugs do not tend to raise intraocular pressure in patients with both glaucoma and asthma. Option D is also misleading as muscarinic agonists and beta blockers are not typically used for acute asthma management.
Educationally, it is important for healthcare professionals to understand the potential cross-reactivity of drugs used in different conditions and how they can impact patients with comorbidities. This knowledge is essential for safe and effective patient care, highlighting the significance of considering individual patient profiles and medical history when prescribing medications.
Option A is correct because muscarinic agonists and beta blockers are contraindicated or pose great risks for individuals with asthma. It is crucial for healthcare providers to be aware of this interaction to avoid adverse effects in patients with both glaucoma and asthma.
Options B, C, and D are incorrect. Option B incorrectly suggests that these drugs degranulate mast cells and cause bronchoconstriction. Option C is inaccurate as these drugs do not tend to raise intraocular pressure in patients with both glaucoma and asthma. Option D is also misleading as muscarinic agonists and beta blockers are not typically used for acute asthma management.
Educationally, it is important for healthcare professionals to understand the potential cross-reactivity of drugs used in different conditions and how they can impact patients with comorbidities. This knowledge is essential for safe and effective patient care, highlighting the significance of considering individual patient profiles and medical history when prescribing medications.